Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $128.92 million as of December 5, 2025. Its market cap has increased by 223.72% in one year.

Market Cap

128.92M

Enterprise Value

129.12M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$1.73

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 128.92M, an increase of 1,769.50%. That is a compound annual growth rate of 10.14%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	127.61M	320.86%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	807.30M
Elite Pharmaceuticals	569.32M
Glass House Brands	503.27M
CytoDyn	416.55M
American Oncology Network	363.17M
Northwest Biotherapeutics	359.36M
Silence Therapeutics	295.21M
Nika Pharmaceuticals	259.91M

Market Cap Rankings